Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan - PubMed

IFX might be an effective and tolerable treatment for refractory KD.
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov